{
    "clinical_study": {
        "@rank": "99124", 
        "arm_group": [
            {
                "arm_group_label": "High intensity aerobic interval training", 
                "arm_group_type": "Experimental", 
                "description": "Type 2 diabetes subjects will complete 8 weeks of high intensity aerobic interval exercise training."
            }, 
            {
                "arm_group_label": "Continuous moderate intensity exercise", 
                "arm_group_type": "Experimental", 
                "description": "Type 2 diabetes subjects will complete 8 weeks of continuous moderate intensity exercise training."
            }, 
            {
                "arm_group_label": "Non-exercise control group", 
                "arm_group_type": "No Intervention", 
                "description": "Type 2 diabetes subjects assigned to the non-exercise control group will maintain their normal lifestyle for 8 weeks."
            }, 
            {
                "arm_group_label": "Healthy control group", 
                "arm_group_type": "No Intervention", 
                "description": "Healthy subjects will be assigned to the healthy control group and will undergo baseline measures only."
            }
        ], 
        "brief_summary": {
            "textblock": "The study objectives are:\n\n        1. To compare cardiovascular function in type 2 diabetes patients vs. healthy controls.\n\n        2. To compare the effect of 8 weeks of aerobic interval training versus continuous\n           moderate exercise on cardiovascular function in adults with type 2 diabetes.\n\n        3. To examine the mechanisms underlying the exercise-related changes in cardiovascular\n           function.\n\n      The investigators hypothesize that compared to continuous moderate intensity exercise\n      training, interval training will be more effective in improving cardiovascular function in\n      adults with type 2 diabetes."
        }, 
        "brief_title": "Effect of Aerobic Interval Training on Cardiovascular Function in Type 2 Diabetes", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 2 Diabetes", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "detailed_description": {
            "textblock": "Cardiovascular function will be measured at baseline in adults with type 2 diabetes and in\n      age-matched healthy controls.  Research volunteers with type 2 diabetes who meet the\n      inclusion criteria will be randomized to the aerobic interval training group, continuous\n      moderate exercise group or non-exercise control group.  At the end of the 8-week randomized\n      control exercise intervention, baseline measures will be repeated."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria for type 2 diabetes :\n\n          -  Diagnosis of type 2 diabetes\n\n          -  Sedentary or minimally physically active for at least the prior 1 year\n\n          -  Able to give consent\n\n        Inclusion criteria for healthy control group:\n\n          -  Sedentary or minimally physically active for at least the prior 1 year\n\n          -  Able to give consent\n\n        Exclusion Criteria:\n\n          -  History of diabetic proliferative retinopathy, autonomic or peripheral neuropathy\n\n          -  History of any relevant cardiovascular diseases (myocardial infarction, angina\n             pectoris, history of coronary artery bypass surgery or angioplasty, congestive heart\n             failure, or arrhythmia)\n\n          -  Hypertension (\u2265160 mmHg systolic or \u2265100 mmHg diastolic)\n\n          -  History of renal impairment\n\n          -  History of gout or hyperuricemia\n\n          -  History of hepatic disease or infection with hepatitis B, C\n\n          -  History of seizures, or other relevant on-going or recurrent illness\n\n          -  Recent (within 3 months) or recurrent hospitalizations\n\n          -  Use of tobacco products\n\n          -  >5 % weight change in the prior 6 months.\n\n          -  Current intake of medications that may affect study results\n\n          -  Premenopausal women taking oral contraceptives and postmenopausal women taking\n             hormone replacement therapy.\n\n          -  Pregnancy (positive urine pregnancy test) or lactation\n\n          -  For the healthy control group, history of diabetes."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "79 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "118", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01883258", 
            "org_study_id": "280-2012"
        }, 
        "intervention": [
            {
                "arm_group_label": "High intensity aerobic interval training", 
                "description": "Supervised aerobic interval training will be performed on bicycles 4 times per week for 8 weeks.  Each training session will last 40 minutes and will consist of 10-minute warm up at 70% of maximal heart rate (HRmax), four 4-minute intervals at 90% of HRmax with 3-min active recovery at 70% of HRmax and 5-minute cool down at 70% of HRmax.", 
                "intervention_name": "High intensity aerobic interval training", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Continuous moderate intensity exercise", 
                "description": "Supervised exercise training will be performed on bicycles 4 times per week for 8 weeks.  Each training session will last 47 minutes and will consist of continuous moderate intensity cycling at 70% of HRmax.", 
                "intervention_name": "Continuous moderate intensity exercise", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 7, 2014", 
        "location": {
            "contact": {
                "email": "ddchristou@ufl.edu", 
                "last_name": "Demetra D Christou, Ph.D", 
                "phone": "352-294-1715"
            }, 
            "facility": {
                "address": {
                    "city": "Gainesville", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "32611"
                }, 
                "name": "University of Florida"
            }, 
            "investigator": {
                "last_name": "Demetra D Christou, Ph.D", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Mechanisms of Cardiovascular Dysfunction and Effect of Aerobic Exercise Training in Adults With Type 2 Diabetes", 
        "overall_contact": {
            "email": "ddchristou@ufl.edu", 
            "last_name": "Demetra D Christou, Ph.D", 
            "phone": "352-294-1715"
        }, 
        "overall_official": {
            "affiliation": "University of Florida", 
            "last_name": "Demetra D Christou, Ph.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Brachial flow mediated dilation using ultrasonography", 
            "measure": "Change in vascular endothelial function", 
            "safety_issue": "No", 
            "time_frame": "At baseline and after 8 weeks of exercise training"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01883258"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Blood and cellular markers of adiponectin, oxidative stress and inflammation.", 
                "measure": "Change in factors related with endothelial function", 
                "safety_issue": "No", 
                "time_frame": "At baseline and after 8 weeks of exercise training"
            }, 
            {
                "description": "Arterial stiffness (pulse wave velocity) and wave reflection (augmentation index) will be measured using the SphygmoCor device.", 
                "measure": "Change in arterial stiffness", 
                "safety_issue": "No", 
                "time_frame": "At baseline and after 8 weeks of exercise training"
            }, 
            {
                "description": "Left ventricular systolic and diastolic function will be measured using echocardiography.", 
                "measure": "Change in cardiac function", 
                "safety_issue": "No", 
                "time_frame": "At baseline and after 8 weeks of exercise training"
            }, 
            {
                "description": "Maximal oxygen consumption will be measured using online computer-assisted open-circuit spirometry during incremental treadmill exercise.", 
                "measure": "Change in maximal oxygen consumption", 
                "safety_issue": "No", 
                "time_frame": "At baseline and after 8 weeks of exercise training"
            }
        ], 
        "source": "University of Florida", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Florida", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor)", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}